Apocrine Carcinoma, Adenopathies, and Raised TAG‐72 Serum Tumor Marker
Apocrine Carcinoma, Adenopathies, and Raised TAG‐72 Serum Tumor Marker
复制标题
顶浆腺癌、腺病和 TAG-72 血清肿瘤标志物升高
DOI:
10.1111/j.1524-4725.2004.30180.x
复制
发表时间:
2004
影响因子:
2.4
通讯作者:
Jorge Soto De Delas
中科院分区:
文献类型:
--
作者:
J. Santos;J. F. de Quirós;J. S. del Río;M. T. Allende;M. Folgueras;Jorge Soto De Delas
BACKGROUND The detection of tumor-associated glycoprotein-72 in the serum of patients with carcinomas, basically of the colon, has proved to be of great use in the follow-up of these gastrointestinal adenocarcinomas. RESULTS We report the case of a male patient presenting adenopathies in the right axilla. The histologic study of an adjacent skin tumor enabled the diagnosis of a cutaneous apocrine carcinoma. Among the studies made, the increase in the serum antibody CA72.4 can be highlighted. The tumor marker was negative after the extirpation of the skin tumor and the axillary adenopathies. CONCLUSION To our best knowledge, this is the first case in which a tumor serum marker is associated with a cutaneous apocrine carcinoma, a fact that should be confirmed with further patients. Its use in the monitoring of this infrequent skin neoplasia is also noteworthy.